The circadian clock protein REVERBα inhibits pulmonary fibrosis development
Peter S. Cunningham,Peter Meijer,Alicja Nazgiewicz,Simon G. Anderson,Lee A. Borthwick,James Bagnall,Gareth B. Kitchen,Monika Lodyga,Nicola Begley,Rajamiyer V. Venkateswaran,Rajesh Shah,Paul F. Mercer,Hannah J. Durrington,Neil C. Henderson,Karen Piper-Hanley,Andrew J. Fisher,Rachel C. Chambers,David A. Bechtold,Julie E. Gibbs,Andrew S. Loudon,Martin K. Rutter,Boris Hinz,David W. Ray,John F. Blaikley
DOI: https://doi.org/10.1073/pnas.1912109117
IF: 11.1
2019-12-26
Proceedings of the National Academy of Sciences
Abstract:Significance The circadian clock plays an essential role in energy metabolism and inflammation. In contrast, the importance of the clock in the pathogenesis of fibrosis remains poorly explored. This study describes a striking alteration in circadian biology during pulmonary fibrosis where the relatively arrhythmic alveolar structures gain circadian but asynchronous rhythmicity due to infiltration by fibroblasts. Disruption of the clock in these cells, which are not widely implicated in circadian pathophysiology, results in a profibrotic phenotype. Translation of these findings in humans revealed previously unrecognized important circadian risk factors for pulmonary fibrosis (sleep length, chronotype, and shift work). In addition, targeting REVERBα repressed collagen secretion from human fibrotic lung tissue, making this protein a promising therapeutic target.
multidisciplinary sciences